BARICITINIB

Clinical Indication

Moderate to severe atopic dermatitis

Comments

In line with NICE TA681

Implementation date 3rd June 2021

Date of classification

May 2021

Review date

May 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).